Sangamo Announces Updated Phase 1/2 STAAR Study Data in Fabry Disease Showing Sustained Benefit, Improvements in Kidney Function and a Favorable Safety Profile

Click here to view

Presentation

Poster: Development of a Robust Zinc Finger Activation Platform for Treatment of Neurological Disorders

Download PDF